STOCK TITAN

Guardant Health director proposes $31K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Guardant Health, Inc. director Alex M Azar II reported that 207 common shares may be sold, with an aggregate market value of $30,959 and an approximate sale date of November 16, 2026. The notice lists Charles Schwab & Co., Inc. as broker. The shares were acquired through a restricted-stock lapse on November 12, 2026, as equity compensation. The notice also lists prior sales of 826 shares on September 16, 2026, for gross proceeds of $144,550, and 69 shares on October 14, 2026, for gross proceeds of $11,032.

Shares reported for sale 207 shares Approximate sale date November 16, 2026
Aggregate market value $30,959 Shares reported for sale
Shares outstanding 135,285,975 shares Reported in the securities information section
Prior shares sold 826 shares September 16, 2026
Prior gross proceeds $144,550 Sale on September 16, 2026
Prior shares sold 69 shares October 14, 2026
Prior gross proceeds $11,032 Sale on October 14, 2026
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Restricted Stock Lapse financial
"Restricted Stock Lapse - See Remarks"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GH shares did Alex M Azar II report for sale?

The notice lists 207 common shares, with an aggregate market value of $30,959 and an approximate sale date of November 16, 2026. It names Charles Schwab & Co., Inc. as broker.

What date is listed for Alex M Azar II's GH Rule 10b5-1 plan?

The notice lists May 21, 2026 as the plan adoption or instruction date for reliance on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading